WebJun 29, 2011 · The average dose intensity of cisplatin (26.5 mg/m 2 /week) was equivalent to that of three-weekly regimen (28.9 mg/m 2 /week) . With regard to toxicity, the rate of Grade 3 or greater leukopenia and mucositis in the three-weekly cisplatin regimen in patients with unresectable disease was reported to be 42.1% and 45.2%, respectively. WebApr 10, 2024 · Radiation-induced oral mucositis (RIOM) is an important treatment-limiting toxicity. Benzydamine hydrochloride was recommended to prevent oral mucositis. ... Once-a-Week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial. J. Clin. Oncol. 2024; 36: 1064 …
Chemotherapy-induced oral mucositis is associated with …
WebOct 16, 2024 · Approximately 70% of patients with head and neck cancer (HNC) receiving concurrent cisplatin and radiation experience severe oral mucositis (SOM), defined as grade 3 to 4 by the WHO scale. 1 - 3 SOM causes pain that potentially requires narcotics; adversely affects nutrition (including requiring a feeding tube), hydration, speech, … WebSep 14, 2024 · A rat model of mucositis and pica was established by daily intraperitoneal injection of cisplatin (6 mg/kg) for 3 days. In the probiotic+cisplatin group, predaily intragastric injection of the probiotic mixture (1 × 10 9 CFU/kg BW) was administrated for 1 week before cisplatin injection. This was then followed by further daily probiotic ... ggh rental apartments
Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 ...
WebAug 30, 2024 · Make sure to take care of any current issues with your mouth. These can include gum disease, cavities or teeth that need to be pulled. Any pain or infections in … WebFeb 1, 2024 · Descriptions. Cisplatin injection is used to treat advanced cancer of the bladder, ovaries, or testicles. Cisplatin is an antineoplastic agent (cancer medicine). … WebMay 22, 2024 · Nimotuzumab is a significant factor for development of grade 3 and above oral mucositis. Cisplatin-based chemoradiotherapy (CRT) has been the standard treatment for patients with locally advanced head and neck squamous cell carcinomas (LA-HNSCC), given with the aim of preserving function and improving survival [ 1 ]. ggh samson - merino wolle